Gallo Guido, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 792
EU - Europa 561
AS - Asia 333
AF - Africa 20
SA - Sud America 2
Totale 1.708
Nazione #
US - Stati Uniti d'America 790
SE - Svezia 149
CN - Cina 131
SG - Singapore 108
DE - Germania 95
IT - Italia 87
UA - Ucraina 77
IE - Irlanda 48
IN - India 37
FR - Francia 35
ID - Indonesia 30
FI - Finlandia 22
GB - Regno Unito 22
CI - Costa d'Avorio 15
RU - Federazione Russa 13
TR - Turchia 13
OM - Oman 7
HK - Hong Kong 5
BE - Belgio 4
NL - Olanda 3
AT - Austria 2
BR - Brasile 2
MA - Marocco 2
NG - Nigeria 2
BW - Botswana 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
JP - Giappone 1
MX - Messico 1
TW - Taiwan 1
Totale 1.708
Città #
Chandler 203
Singapore 90
Jacksonville 61
Dublin 48
New York 44
Ashburn 39
San Mateo 36
Ann Arbor 35
Jakarta 30
Nanjing 29
Wilmington 26
Cattolica 23
Dearborn 20
Boston 18
Nanchang 18
Lawrence 16
Abidjan 15
Marseille 15
Izmir 13
Los Angeles 13
Milan 13
Beijing 12
Seattle 12
Moscow 11
Princeton 10
Redwood City 10
Rome 8
Fairfield 6
Hebei 6
Ariano Irpino 5
Boardman 5
Helsinki 5
Houston 5
Kunming 5
London 5
Zhengzhou 5
Hefei 4
Hong Kong 4
Jiaxing 4
Lancaster 4
Leawood 4
Tianjin 4
University Park 4
Woodbridge 4
Bari 3
Brussels 3
Changsha 3
Detroit 3
Falkenstein 3
Hangzhou 3
Paris 3
Redmond 3
Simi Valley 3
Amsterdam 2
Andover 2
Costa Mesa 2
Fuzhou 2
Katsina 2
Lviv 2
Mountain View 2
Nimis 2
Orange 2
Oujda 2
Padova 2
Pune 2
Shenyang 2
São Paulo 2
Aprilia 1
Augusta 1
Bremen 1
Budapest 1
Cambridge 1
Central District 1
Changchun 1
Chengdu 1
Civitavecchia 1
Florence 1
Fremont 1
Gaborone 1
Indiana 1
Jinan 1
Laarne 1
Lanzhou 1
Lappeenranta 1
Mazzano Romano 1
Mexico City 1
Millbury 1
Milwaukee 1
Molfetta 1
Monmouth Junction 1
Mumbai 1
Nantong 1
Naples 1
Norwalk 1
Nuremberg 1
Ottawa 1
Palermo 1
Philadelphia 1
Phoenix 1
San Diego 1
Totale 1.035
Nome #
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma 98
Targeting the hallmarks of ovarian cancer: The big picture 81
Sexual dimorphism in medulloblastoma features 79
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? 77
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 77
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 76
Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy 75
Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. 73
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 70
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer. 69
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 68
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 66
The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer 64
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 64
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 60
Mitochondrial estrogen receptor beta 2 drives antiapoptotic pathways in advanced serous ovarian cancer 60
Hormone receptor expression profile of low-grade serous ovarian cancers 60
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 58
The dualistic model of endometrial cancer: The challenge of classifying grade 3 endometrioid carcinoma 57
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 55
Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors? 55
Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors? 55
The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways 53
The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer 49
Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts. 40
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. 36
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 33
Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors 28
Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer 11
Totale 1.747
Categoria #
all - tutte 8.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 0 0 0 0 0 14 27 1 6 5 39 17
2020/2021146 6 16 7 13 20 10 13 3 19 5 25 9
2021/2022192 16 14 6 11 15 4 2 33 8 10 39 34
2022/2023517 61 85 42 69 33 69 32 35 81 5 2 3
2023/2024246 13 83 1 8 7 50 10 6 3 13 35 17
2024/2025170 14 16 47 27 41 25 0 0 0 0 0 0
Totale 1.747